Table 3.
Estimated PM2.5-related Morbidity Effects in 2005, 2011 and 2014.
| 2005 | 2011 | 2014 | |
|---|---|---|---|
| PM-related effects | |||
| Non-fatal heart attacks | 125,000 (33,000–200,000) | 116,000 (31,000–190,000) | 110,000 (28,000–170,000) |
| Cardiovascular Hospital Admissions | 44,000 (20,000–79,000) | 40,000 (18,000–72,000) | 29,000 (13,000–52,000) |
| Respiratory hospital admissions | 35,000 (−10,000–67,000) | 32,000 (−9000–59,000) | 27,000 (−8300–52,000) |
| Emergency Room Visits for Asthma | 77,000 (−30,000–160,000) | 64,000 (−25,000–130,000) | 68,000 (−26,000–140,000) |
| Exacerbated Asthma | 11,500,000 (−300,000–78,000,000) | 9,400,000 (−240,000–65,000,000) | 8800,000 (−220,000–62,000,000) |
| Lower Respiratory Symptoms | 2700,000 (1100,000–4,00,000) | 2200,000 (890,000–3,400,000) | 2100,000 (840,000–3,200,000) |
| Upper Respiratory Symptoms | 4300,000 (780,000–7,700,000) | 3,500,000 (630,000–6,200,000) | 3200,000 (590,000–5,800,000) |
| Acute Respiratory Symptoms | 110,000,000 (91,000,000–130,000,000) | 97,000,000 (79,000,000–110,000,000) | 92,000,000 (76,000,000–110,000,000) |
| Lost Work Days | 19,000,000 (16,000,000–22,000,000) | 17,000,000 (14,000,000–19,000,000) | 16,000,000 (13,000,000–18,000,000) |
| Acute Bronchitis | 200,000 (−57,000–380,000) | 170,000 (−45,000–330,000) | 160,000 (−43,000–310,000) |